138 related articles for article (PubMed ID: 12059028)
1. Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line.
Gill JS; Zhu X; Moore MJ; Lu L; Yaszemski MJ; Windebank AJ
Biomaterials; 2002 Jul; 23(13):2773-81. PubMed ID: 12059028
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
[TBL] [Abstract][Full Text] [Related]
3. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres.
De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R
J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489
[TBL] [Abstract][Full Text] [Related]
4. [Regulation of tissue factor expression in brain microvascular endothelial cells by PLA nanoparticles coating NF-kappaB decoy oligonucleotides].
Hu Y; Wang HF; Sun WQ; Xie CS; Wei WN; Zheng JE; Yao JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):534-8. PubMed ID: 16468330
[TBL] [Abstract][Full Text] [Related]
5. Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide.
Park YG; Park S; Lim SO; Lee MS; Ryu CK; Kim I; Cho-Chung YS
Biochem Biophys Res Commun; 2001 Mar; 281(5):1213-9. PubMed ID: 11243864
[TBL] [Abstract][Full Text] [Related]
6. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy.
Osako MK; Nakagami H; Morishita R
Curr Top Med Chem; 2012; 12(15):1603-7. PubMed ID: 22762556
[TBL] [Abstract][Full Text] [Related]
7. Oligonucleotide decoy to NF-kappaB slowly released from PLGA microspheres reduces chronic inflammation in rat.
De Stefano D; De Rosa G; Maiuri MC; Ungaro F; Quaglia F; Iuvone T; Cinelli MP; La Rotonda MI; Carnuccio R
Pharmacol Res; 2009 Jul; 60(1):33-40. PubMed ID: 19427583
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function.
Lu L; Yaszemski MJ; Mikos AG
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S82-91. PubMed ID: 11314800
[TBL] [Abstract][Full Text] [Related]
9. NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge Resorption.
Huang AC; Ishida Y; Li K; Rintanalert D; Hatano-Sato K; Oishi S; Hosomichi J; Usumi-Fujita R; Yamaguchi H; Tsujimoto H; Sasai A; Ochi A; Watanabe H; Ono T
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835111
[TBL] [Abstract][Full Text] [Related]
10. Effects of transforming growth factor beta1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates.
Peter SJ; Lu L; Kim DJ; Stamatas GN; Miller MJ; Yaszemski MJ; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):452-62. PubMed ID: 10737888
[TBL] [Abstract][Full Text] [Related]
11. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
Lu L; Stamatas GN; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
[TBL] [Abstract][Full Text] [Related]
12. Effects of biodegradable polymer particles on rat marrow-derived stromal osteoblasts in vitro.
Wake MC; Gerecht PD; Lu L; Mikos AG
Biomaterials; 1998 Jul; 19(14):1255-68. PubMed ID: 9720889
[TBL] [Abstract][Full Text] [Related]
13. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.
Kim WU; Lee WK; Ryoo JW; Kim SH; Kim J; Youn J; Min SY; Bae EY; Hwang SY; Park SH; Cho CS; Park JS; Kim HY
Arthritis Rheum; 2002 Apr; 46(4):1109-20. PubMed ID: 11953991
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line.
Fang Y; Sun H; Zhai J; Zhang Y; Yi S; Hao G; Wang T
Asian Pac J Cancer Prev; 2011; 12(10):2721-6. PubMed ID: 22320981
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.
Matsushita H; Morishita R; Nata T; Aoki M; Nakagami H; Taniyama Y; Yamamoto K; Higaki J; Yasufumi K; Ogihara T
Circ Res; 2000 May; 86(9):974-81. PubMed ID: 10807870
[TBL] [Abstract][Full Text] [Related]
16. Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-co-glycolic)acid microspheres.
Carrasquillo KG; Ricker JA; Rigas IK; Miller JW; Gragoudas ES; Adamis AP
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):290-9. PubMed ID: 12506087
[TBL] [Abstract][Full Text] [Related]
17. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease.
Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y
Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.
Guh JY; Huang JS; Chen HC; Hung WC; Lai YH; Chuang LY
Am J Kidney Dis; 2001 Nov; 38(5):1096-104. PubMed ID: 11684565
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.
Miyake T; Aoki M; Morishita R
Cardiovasc Res; 2008 Sep; 79(4):706-14. PubMed ID: 18515844
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.
Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M
Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
